Saxenda (liraglutide) is a GLP-1 agonist injection pen medication. It helps with sustained weight loss for adults with obesity, adults with overweight who are experiencing weight-related health issues ...

Saxenda (liraglutide) is a brand-name drug prescribed for weight management in adults and some children. Saxenda comes as an injection pen that’s typically used once per day. Your doctor will ...

Saxenda (liraglutide) is a GLP-1 agonist injection pen medication used to support long-term weight loss in adults with obesity, adults with overweight and weight-related health issues, and certain ...

Novo Nordisk ($NVO) says its new drug Saxenda has a niche in the U.S. obesity market. Now, the Danish drugmaker has the chance to prove it. Saxenda is rolling out ...

Saxenda Approved for Weight Management The FDA has approved Saxenda (liraglutide [rDNA origin]) injection for chronic weight management. Saxenda is the first glucagon-like peptide-1 (GLP-1) receptor ...

Saxenda Approved for Weight Management Novo Nordisk announced that the FDA has approved Saxenda (liraglutide [rDNA origin]) injection for chronic weight management. Saxenda is the first glucagon-like ...

Saxenda® (liraglutide) injection 3 mg becomes the first FDA-approved therapy to treat obesity in adolescents in more than a decade PLAINSBORO, N.J., Dec. 4, 2020 /PRNewswire/ -- Novo Nordisk today ...

Saxenda (liraglutide) is a prescription drug used for weight management. The drug comes as a liquid solution that you inject daily. Saxenda is used in adults and some children to help with weight loss ...